Showing results (61-70 of 755) with videos related to
Sort By:
Pageof 76
Gut|August 21, 2016
Blockade of αEβ7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivoSebastian Zundler, Daniela Schillinger, Anika Fischer, et al.Cancer Research|June 29, 2012
Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitisKatharina Gerlach, Carolin Daniel, Hans A Lehr, et al.Clinical Oral Investigations|August 12, 2021
Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients-a preliminary studyMayte Buchbender, Jakob Fehlhofer, Peter Proff, et al.Therapeutic Advances in Gastroenterology|October 9, 2024
Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experienceKim Wagner, Tanja M Müller, Francesco Vitali, et al.Plos One|March 26, 2013
Confocal laser endomicroscopy for in vivo diagnosis of Clostridium difficile associated colitis - a pilot studyHelmut Neumann, Claudia Günther, Michael Vieth, et al.Journal of Crohn'S & Colitis|June 10, 2025
ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanismLi-Juan Liu, Tanja M Müller, Mark Dedden, et al.Clinical and Translational Gastroenterology|May 16, 2022
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte SubsetsEmily Becker, Anna Schweda, Karen A-M Ullrich, et al.Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.Seminars in Immunology|December 17, 2025
New insights into Th9 cells in inflammatory bowel diseasesMarkus F NeurathScience Translational Medicine|December 14, 2022
Targeting cytokines in inflammatory bowel diseaseMarkus F NeurathPageof 76